US Patent Issued to Bright Peak Therapeutics on Aug. 12 for "Immune antigen specific IL-18 immunocytokines and uses thereof" (French, German, American, Swiss Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,631, issued on Aug. 12, was assigned to Bright Peak Therapeutics AG (Basel, Switzerland).

"Immune antigen specific IL-18 immunocytokines and uses thereof" was invented by Vijaya Raghavan Pattabiraman (Volketswil, Switzerland), Bertolt Kreft (Kleinmachow, Germany), Jean-Philippe Carralot (Saint-Louis, France), Arnaud Goepfert (Sierentz, France), Kea Martin (Istein, Germany) and Andrew Chi (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to modified immunocytokine compositions comprising antibodies or antigen binding fragments specific for immune cell antigens and IL-18 polypeptides. Also provided herein are met...